Targeted Immunotherapy With a Checkpoint Inhibitor in Combination With Chemotherapy: A New Clinical Paradigm in the Treatment of Triple-Negative Breast Cancer. Biomol Biomed 2019, 19 (3), 227-233. https://doi.org/10.17305/bjbms.2019.4204.